Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
0.73 USD
↘ 0.07 (8.75%)AT CLOSE (11:59 AM EDT)
0.73
↗ 0.00 (0.41%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
0.73
↗ 0.00 (0.41%)
🔴Market: CLOSED
Open?$0.80
High?$0.80
Low?$0.72
Prev. Close?$0.80
Volume?306.4K
Avg. Volume?377.6K
VWAP?$0.76
Rel. Volume?0.81x
Bid / Ask
Bid?$0.63 × 100
Ask?$0.90 × 100
Spread?$0.27
Midpoint?$0.76
Valuation & Ratios
Market Cap?25.3M
Shares Out?30.1M
Float?19.7M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?1.58
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A

LGVN is currently priced at $0.73. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. LGVN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
25.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.91Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.91%High
Short Interest?2.3M
Days to Cover?5.3
Free Float19.7M
Avg Daily Volume444.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.88Strong
Quick Ratio?3.88Strong
Cash Ratio?3.63Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
85
1.58CHEAP▾
P/S?
Peers
100
S&P
3
20.79HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
17
7.83HIGH▾
Returns & Efficiency
ROE?
S&P
3
-140.0%WEAK▾
ROA?
S&P
3
-105.8%WEAK▾
Cash Flow & Enterprise
FCF?$-18536000
Enterprise Value?$9.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist